14th ANNUAL BIOTECH IN EUROPE FORUM For Global Partnering & Investment 9/30 – 10/1/2014 • Congress Center Basel – SACHS Associates, London
Financial/Advisory Investors attending the 2014 Forum include: |
AbbVie Biotech Ventures, Inc. Advent Life Sciences Aescap Venture Management BV Aglaia Biomedical Ventures B.V. Amgen Ventures AmorChem apo Asset Management GmbH Aravis AG Aurum Ventures MKI Ltd. Bay City Capital BB Biotech Ventures Bergmann zur Hausen & Cie. GmbH BioMedPartners AG Boehringer Ingelheim Venture Fund Breslin AG Capricorn Venture Partners CD-Venture GmbH Cederberg GmbH CFP BioConnect AG Citi Group Creathor Ventures Cukierman & Co. Life Sciences Deutsche Bank AG Edison Investment Research Edmond de Rothschild Investment Partners Ernst & Young European Investment Fund Excellentia Gloabl Partners F. Hoffmann-La Roche AG Roche Venture Fund Forbion Capital Partners Fraser Finance Global Life Science Ventures HBM Partners AG HealthCap High-Tech Gruenderfonds Management GmbH IBB: Venture Capital Berlin Imperial Innovations Industrifonden JSB Partners LP Knoll Capital Management Kreos Capital Life Sciences Partners Lundbeckford Ventures LSP Medical Strategy GmbH MedVenture Partners GmbH MRL Ventures, Merck & Co., Inc. MS Ventures Nextech Invest Ltd NGN Captial Novartis Venture Fund Novo A/S NRW Bank Omega Funds Oriel Securities Limited Osprey Capital Partners Inc. Percipient Capital Pfizer Venture Investments Piper Jaffray Privateq Advisors AG Remaco AG RMI Partners Rosetta Capital Limited S.R.One, Limited SBS Investments Seroba Kernel Life Sciences Ltd. Siemens Technology Accelerator GmbH Silicon Valley Bank Sofinnova Partners Spinnovator – Ascenion GmbH Takeda Ventures, Inc. TEL Venture Capital, Inc Teralys Capital The Welcome Trust Torreya Partners (Europe) LLC TVM Capital Ventac Partners Vesalius Biocapital VI Partners Vinci Capital Visium Asset UK LLP Warwick Ventures Ltd Wellington Partners XOventure GmbH Yorkville Advisors, LLC Ysios Capital Partners |
Leave a Reply